1. Home
  2. Africa

Still hope for successful AIDS vaccine

Researchers on Thursday expressed the hope that new approaches to developing an HIV/AIDS vaccine could eventually vanquish the global pandemic.

Dr Barton Haynes, a vaccine researcher at Duke University in North Carolina, in the US, said with so many different HIV/AIDS vaccine trials taking place globally, the chances of finding one that worked were good.

According to the International AIDS Vaccine Initiative (IAVI), there are currently two dozen different vaccines being tested in 27 trials involving human volunteers around the world.

Reuters quoted Haynes as saying: "It is safe to say we have reached the beachhead in the quest for an HIV/AIDS vaccine."

At the recent 2003 HIV/AIDS Vaccine conference in New York, Haynes said the pace of research had accelerated, despite the first vaccine to complete all three phases of human testing, AIDSVax, by the pharmaceutical company VaxGen, having failed earlier this year to protect humans against HIV.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join